Abstract
Amniotic fluid-derived stem cells (AFSC) have been shown to be broadly multipotent and non-tumorogenic. Previous studies of direct mixing of AFSC and neonatal rat ventricle myocytes indicated evidence of AFSC cardiogenesis. In this study, we examined human AFSC cardiogenic potential in indirect co-culture with human cardiac cells in conditions that eliminated the possibility of cell fusion. Human AFSC in contact with human cardiac cells showed expression of cardiac troponin T (cTnT) in immunohistochemistry, and no evidence of cell fusion was found through fluorescent in situ hybridization. When indirectly co-cultured with cardiac cells, human AFSC in contact with cardiac cells across a thin porous membrane showed a statistically significant increase in cTnT expression compared to non-contact conditions but lacked upregulation of calcium modulating proteins and did not have functional or morphological characteristics of mature cardiomyocytes. This suggests that contact is a necessary but not sufficient condition for AFSC cardiac differentiation in co-culture with cardiac cells.
Similar content being viewed by others
Abbreviations
- AFSC:
-
Amniotic fluid derived stem cells
- CHD:
-
Congenital heart defects
- RVOT:
-
Right ventricular out flow tract
- CM:
-
Cardiomyocytes
- NRVM:
-
Neonatal rat ventricular myocytes
References
Acquistapace, A., T. Bru, P.-F. Lesault, F. Figeac, A. E. Coudert, O. le Coz, C. Christov, X. Baudin, F. Auber, R. Yiou, J.-L. Dubois-Randé, and A.-M. Rodriguez. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells (Dayton, Ohio) 29:812–824, 2011.
Benavides, O., and J. Petsche. Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng. Part A 18:1123–1131, 2012.
Bistola, V., M. Nikolopoulou, A. Derventzi, A. Kataki, N. Sfyras, N. Nikou, M. Toutouza, P. Toutouzas, C. Stefanadis, and M. M. Konstadoulakis. Long-term primary cultures of human adult atrial cardiac myocytes: cell viability, structural properties and BNP secretion in vitro. Int. J. Cardiol. 131:113–122, 2008.
Chiavegato, A., S. Bollini, M. Pozzobon, A. Callegari, L. Gasparotto, J. Taiani, M. Piccoli, E. Lenzini, G. Gerosa, I. Vendramin, E. Cozzi, A. Angelini, L. Iop, G. F. Zanon, A. Atala, P. De Coppi, and S. Sartore. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J. Mol. Cell. Cardiol. 42:746–759, 2007.
Connell, J. P., E. Augustini, K. J. Moise, A. Johnson, and J. G. Jacot. Formation of functional gap junctions in amniotic fluid-derived stem cells induced by transmembrane co-culture with neonatal rat cardiomyocytes. J. Cell Mol. Med. 17:774–781, 2013.
De Coppi, P., G. Bartsch, M. M. Siddiqui, T. Xu, C. C. Santos, L. Perin, G. Mostoslavsky, A. C. Serre, E. Y. Snyder, J. J. Yoo, M. E. Furth, S. Soker, and A. Atala. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25:100–106, 2007.
Du, Z. D., Z. M. Hijazi, C. S. Kleinman, N. H. Silverman, and K. Larntz. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol. 39:1836–1844, 2002.
French, K. M., A. V. Boopathy, J. A. DeQuach, L. Chingozha, H. Lu, K. L. Christman, and M. E. Davis. A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro. Acta Biomater. 8:4357–4364, 2012.
Guan, X., and D. Delo. In vitro cardiomyogenic potential of human amniotic fluid stem cells. J. Tissue Eng. Regen. Med. 5:220–228, 2011. doi:10.1002/term.
Hamilton, B. E., D. L. Hoyert, J. A. Martin, D. M. Strobino, and B. Guyer. Annual summary of vital statistics: 2010–2011. Pediatrics 131:548–558, 2013.
Harris, L., and S. Balaji. Arrhythmias in the adult with congenital heart disease. In: Diagnosis and Management of Adult Congenital Heart Disease, edited by M. Gatzoulis, G. Webb, and P. E. Daubeney. Philadelphia: Elsevier Health Sciences, 2003, pp. 105–113.
Heallen, T., M. Zhang, J. Wang, M. Bonilla-Claudio, E. Klysik, R. L. Johnson, and J. F. Martin. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science (New York, N.Y.) 332:458–461, 2011.
Jacot, J., and J. Wong. Endothelial injury induces vascular smooth muscle cell proliferation in highly localized regions of a direct contact co-culture system. Cell Biochem. Biophys. 52:37–46, 2008.
Kehat, I., and D. Kenyagin-Karsenti. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108:363–364, 2001.
Mishra, R., K. Vijayan, E. J. Colletti, D. A. Harrington, T. S. Matthiesen, D. Simpson, S. K. Goh, B. L. Walker, G. Almeida-Porada, D. Wang, C. L. Backer, S. C. Dudley, L. E. Wold, and S. Kaushal. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation 123:364–73, 2011.
Moretti, A., L. Caron, A. Nakano, J. T. Lam, A. Bernshausen, Y. Chen, Y. Qyang, L. Bu, M. Sasaki, S. Martin-Puig, Y. Sun, S. M. Evans, K.-L. Laugwitz, and K. R. Chien. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151–1165, 2006.
Murphy, S., J. Xu, and K. Kochanek. Deaths: final data for 2010. National Vital Statistics Reports 60, 2013.
Naqvi, N., M. Li, J. W. Calvert, T. Tejada, J. P. Lambert, J. Wu, S. H. Kesteven, S. R. Holman, T. Matsuda, J. D. Lovelock, W. W. Howard, S. E. Iismaa, A. Y. Chan, B. H. Crawford, M. B. Wagner, D. I. K. Martin, D. J. Lefer, R. M. Graham, and A. Husain. A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 157:795–807, 2014.
Nygren, J. M., S. Jovinge, M. Breitbach, P. Säwén, W. Röll, J. Hescheler, J. Taneera, B. K. Fleischmann, and S. E. W. Jacobsen. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10:494–501, 2004.
Oh, H., S. B. Bradfute, T. D. Gallardo, T. Nakamura, V. Gaussin, Y. Mishina, J. Pocius, L. H. Michael, R. R. Behringer, D. J. Garry, M. L. Entman, and M. D. Schneider. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. U.S.A. 100:12313–12318, 2003.
Olson, E. N., and D. Srivastava. Molecular pathways controlling heart development. Science 272:671–676, 1996.
Pedrotty, D. M., R. Y. Klinger, R. D. Kirkton, and N. Bursac. Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc. Res. 83:688–697, 2009.
Reller, M., and M. Strickland. Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J. Pediatrics 153:807–813, 2008.
Schuldiner, M., O. Yanuka, J. Itskovitz-Eldor, D. A. Melton, and N. Benvenisty. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. U.S.A. 97:11307–12, 2000.
Steeds, R. P., and D. Oakley. Predicting late sudden death from ventricular arrhythmia in adults following surgical repair of tetralogy of Fallot. QJM 97:7–13, 2003.
Tsai, M.-S., J.-L. Lee, Y.-J. Chang, and S.-M. Hwang. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum. Reprod. (Oxford, England) 19:1450–1456, 2004.
Wozniak, M. A., and C. S. Chen. Mechanotransduction in development: a growing role for contractility. Nature reviews. Mol. Cell Biol. 10:34–43, 2009.
Xin, M., Y. Kim, L. B. Sutherland, M. Murakami, X. Qi, J. McAnally, E. R. Porrello, A. I. Mahmoud, W. Tan, J. M. Shelton, J. A. Richardson, H. A. Sadek, R. Bassel-Duby, and E. N. Olson. Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl Acad. Sci. U.S.A. 110:13839–13844, 2013.
Zhang, P., J. Baxter, K. Vinod, T. N. Tulenko, and P. J. Di Muzio. Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli. Stem Cells Dev. 18:1299–1308, 2009.
Zhou, B., Q. Ma, S. Rajagopal, S. M. Wu, I. Domian, J. Rivera-Feliciano, D. Jiang, A. von Gise, S. Ikeda, K. R. Chien, and W. T. Pu. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454:109–113, 2008.
Zimmermann, W.-H., I. Melnychenko, G. Wasmeier, M. Didié, H. Naito, U. Nixdorff, A. Hess, L. Budinsky, K. Brune, B. Michaelis, S. Dhein, A. Schwoerer, H. Ehmke, and T. Eschenhagen. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12:452–458, 2006.
Acknowledgments
This project is supported by the American Heart Association (Beginning Grant-in-Aid to JGJ.) Amniotic fluid samples were provided by the Fetal Center at Texas Children’s Hospital Pavilion for Women. Pediatric cardiac tissue samples were provided by Division of Congenital Heart Surgery at Texas Children’s Hospital through the Heart Center Biorepository.
Disclosures
There are no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Michael S. Detamore oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Gao, Y., Connell, J.P., Wadhwa, L. et al. Amniotic Fluid-Derived Stem Cells Demonstrated Cardiogenic Potential in Indirect Co-culture with Human Cardiac Cells. Ann Biomed Eng 42, 2490–2500 (2014). https://doi.org/10.1007/s10439-014-1114-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-014-1114-5